Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a Non-invasive Method and Device for Assessing the Degree of Midperipheral Retinal Ischemia in Diabetic Retinopathy.

NCT01546766 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01546766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01546766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a Non-invasive Method and Device for Assessing the Degree of Midperipheral Retinal Ischemia in Diabetic Retinopathy.
Lead sponsor
University of California, Los Angeles
Phase
Observational
Overall status
Completed
Start date
February 28, 2007
Completion date
August 31, 2015
Enrollment
315 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, retinal disorders